Preeclampsia (PE) Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Preeclampsia (PE) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)

Intrauterine Growth Restriction (IUGR)Preeclampsia (PE)Placental Insufficiency
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau154 enrolled2 locationsNCT07098975
Recruiting

Non-Invasive Preeclampsia Screening and Biobank

Preeclampsia (PE)
Sequenom, Inc.6,550 enrolled21 locationsNCT06643741
Recruiting

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

Cardiovascular (CV) RiskPreeclampsia (PE)Fetal Weight
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1,260 enrolled1 locationNCT07356817
Recruiting

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

PregnancyPregnancy ComplicationsPreeclampsia+6 more
University of Tennessee Graduate School of Medicine50 enrolled1 locationNCT06802861
Recruiting

Hyperspectral Imaging for Prediction of Preeclampsia

PreeclampsiaPreeclampsia (PE) Risk
Heidelberg University1,430 enrolled1 locationNCT07106294
Recruiting
Phase 2

Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia

PregnancyPreeclampsia (PE)
University of Mississippi Medical Center60 enrolled1 locationNCT02989025
Recruiting

Endothelial Dysfunction for Prognosis In Patients With preeClampSia

Hypertensive Disorder of PregnancyPreeclampsia (PE)
Heidelberg University385 enrolled1 locationNCT06912477
Recruiting

Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters

Preeclampsia (PE)
iPremom7,473 enrolled11 locationsNCT06716242
Recruiting
Not Applicable

Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

Preeclampsia (PE)
Assistance Publique - Hôpitaux de Paris14,500 enrolled22 locationsNCT05521776
Recruiting
Not Applicable

An Interventional Pilot Study on the Effect of Extra Virgin Olive Oil on Women with Preeclampsia Risk

Preeclampsia (PE) Risk
Yaniv Ovadia156 enrolled1 locationNCT06759545
Recruiting

Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia

Preeclampsia (PE)
Ain Shams Maternity Hospital400 enrolled1 locationNCT06791668